Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Heart Rhythm: Omega-3 fatty acid supplements | Cardiologist ordering habits & AFib outcomes
Friday, October 29, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

Omega-3 fatty acid supplements linked to a higher AFib risk, new meta-analysis confirms

The risk appears to increase more and more when patients consume a higher daily dose. 

READ MORE >
Fish oil supplements are used to reduce cardiovascular disease risk, but can actually increase the risk of atrial fibrillation in some patients.
Share on Twitter Share on Facebook Share on Linkedin

Omega-3 fatty acid supplements linked to a higher AFib risk, new meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
Fish oil supplements are used to reduce cardiovascular disease risk, but can actually increase the risk of atrial fibrillation in some patients.
The risk appears to increase more and more when patients consume a higher daily dose. 
READ MORE >

New research highlights the circadian rhythm seen in heart cells

New data published in Nature Communications may explain why heart problems are so common among shift workers. 

READ MORE >
UW Medicine Regional Heart Center
Share on Twitter Share on Facebook Share on Linkedin

New research highlights the circadian rhythm seen in heart cells

Share on Twitter Share on Facebook Share on Linkedin
UW Medicine Regional Heart Center
New data published in Nature Communications may explain why heart problems are so common among shift workers. 
READ MORE >

High‐billing cardiologists order more tests when treating AFib—but outcomes do not improve

What do these findings say about current billing policies? 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

High‐billing cardiologists order more tests when treating AFib—but outcomes do not improve

Share on Twitter Share on Facebook Share on Linkedin
What do these findings say about current billing policies? 
READ MORE >

Many nonvalvular AFib patients skip DOAC therapy altogether

The study's authors hope their work can help with the development of new interventions that target this issue. 

READ MORE >
pills-384846_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Many nonvalvular AFib patients skip DOAC therapy altogether

Share on Twitter Share on Facebook Share on Linkedin
pills-384846_960_720.jpg
The study's authors hope their work can help with the development of new interventions that target this issue. 
READ MORE >

FDA clears advanced smartwatch capable of detecting AFib

The solution is expected to hit US markets by November. 

READ MORE >
Withings watch
Share on Twitter Share on Facebook Share on Linkedin

FDA clears advanced smartwatch capable of detecting AFib

Share on Twitter Share on Facebook Share on Linkedin
Withings watch
The solution is expected to hit US markets by November. 
READ MORE >

Advanced age, hypertension among predictors of AFib in ESUS patients

The analysis included more than 5,000 patients who received care from December 2014 to January 2018 in one of 42 countries.

READ MORE >
stroke
Share on Twitter Share on Facebook Share on Linkedin

Advanced age, hypertension among predictors of AFib in ESUS patients

Share on Twitter Share on Facebook Share on Linkedin
stroke
The analysis included more than 5,000 patients who received care from December 2014 to January 2018 in one of 42 countries.
READ MORE >

CIED research highlights the close relationship between AFib and ischemic stroke

AFib episodes that last 5.5 hours or longer increase a patient’s risk of ischemic stroke by a significant margin. 

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

CIED research highlights the close relationship between AFib and ischemic stroke

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
AFib episodes that last 5.5 hours or longer increase a patient’s risk of ischemic stroke by a significant margin. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Reprocessed catheters recalled | New payment model almost here | 3-year SMART data | Hypertension drug approved
New payment model on the way | Major recalls could impact care | Policy changes for breakthrough devices
FDA warns public after patient death | Medtronic recalls heart devices | 'Compelling' new PE data | Pushing for TAVR changes
News Alert: Medtronic recalls thousands of surgical devices
New IVL tech overcomes previous limitations | 3-year SMART data looks at TAVR outcomes | Artivion acquires Endospan for $135M
FDA approves next-gen mitral valve | Doctors are first in world to use new TAVR technique | Preventing a common complication
Key updates in PFA & beyond | More good IVL news for Boston Scientific | FDA approves new hypertension drug

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …4
    • Page 5
    • Page 6
    • Page 7
    • Current page 8
    • Page 9
    • Page 10
    • Page 11
    • Page 12 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme